A months-extended legal battle more than state regulations in Ohio’s health-related cannabis plan is lastly coming to an finish for a regional dispensary enterprise related with Acreage Holdings, Inc. (CSE: ACRG.U OTCQX: ACRGF FSE: 0VZ).

Acreage provides consulting and credit to Greenleaf Apothecaries, which had previously opened shops in Canton and Wickliffe, with 3 more websites place on hold when a legal challenge occurred in the summer season. 

The Ohio Board of Pharmacy had appealed a ruling back in August granting a certificate of operation to Greenleaf Apothecaries that would have permitted these new dispensaries to open for business enterprise. 

The Board had previously attempted to cease Greenleaf from gaining that certificate of operation at all, alleging the enterprise had provided misleading or false details in state applications for the certificate. 

Acreage Chief Executive Officer Kevin Murphy announced this morning that the two providers have now reached a resolution with the state. Murphy commented: 

We are thrilled to share the news that Greenleaf Apothecaries has resolved its dispute in a way that makes it possible for Greenleaf to open its remaining 3 dispensaries in Cleveland, Columbus, and Akron, whilst preserving its partnership with Acreage Holdings. As portion of our consulting partnership, which contains a licensing agreement, all 5 of their dispensaries will be known as The Botanist.

The earlier Botanist place in Canton opened back in January, whilst Greenleaf also runs a cultivation facility in Middlefield. Below existing state laws, any person enterprise is only permitted licensing for a maximum of 5 health-related dispensary places. 

In other enterprise news, Acreage is gearing up for a third quarter earnings conference contact to take location subsequent month. Q3 economic reporting will be released soon after close of business enterprise on Nov. 12, with a webcast of the conference contact to be place on-line the subsequent morning. 

Investors are hoping for great news in upcoming quarterly reports as the North American cannabis sector continues to struggle with sharply declining stock costs. Acreage’s stock is at present trading for much less than a quarter of its price tag back in early May possibly.  

Searching to bring in new shoppers for multi-state operations, Acreage is now launching 3 new solution lines outside the regular dried flower solution that involve sublingual breath sprays, flash frozen vape cartridges, and CBD tinctures.